logo
Jefferies sees upside ahead for these stocks — and they pay solid dividends

Jefferies sees upside ahead for these stocks — and they pay solid dividends

CNBC28-05-2025
With earnings season mostly in the rearview mirror, certain names stand out as winners moving forward, according to Jefferies. The firm recently highlighted several buy-rated stocks of companies that beat on earnings and issued solid guidance. It also favors domestic names over foreign, although international stocks are currently outperforming those in the United States. The iShares MSCI All Country World Index ex U.S. ETF (ACWX) has gained about 14% in 2025, while the S & P 500 is fractionally higher so far this year. However, domestically-oriented names are cheap on an absolute basis, as well as relative to names with foreign exposure, U.S. small-mid cap strategist Steven DeSanctis said in a note Tuesday. "Looking across several macro variables and relative performance of Domestic vs. Foreign, performance favors being domestically oriented," he wrote. The strategist added that if oil prices continue to fall and the dollar remains weak, those factors are favorable for domestic names. While the dollar strengthened for the second day on Wednesday, Jefferies thinks the greenback could be in for an extended period of weakness. These names are among those that made the cut; they are mostly mid-cap companies. They also pay dividends, so investors are paid to wait for the stocks to rise. Lamb Weston has 41% upside to Jefferies' $75 price target, as of Tuesday's close, and it has a 2.78% dividend yield. The company, which makes frozen potato products, posted a beat on both the top and bottom lines when it reported fiscal third-quarter results in April. Adjusted earnings were $1.10 per share, versus the 86 cents per share expected from analysts polled by FactSet. Revenue came in at $1.52 billion versus the $1.49 billion consensus estimate. Lamb Weston also reiterated its guidance for the full year. That was "much needed in our view to stem the negative sentiment," said DeSanctis, who acknowledged the company still faces some headwinds. "LW is now engaged with a strategic advisor to explore value creation and operational/cost saving opportunities after an activist got involved in fall '24, with the value of its integrated assets (notably in the US) possibly attractive to potential suitors," he noted. Shares are down 20% year to date. Virtu Financial , on the other hand, is up more than 15% so far this year. Jefferies' $47 price target implies about 14% upside from Tuesday's close. The high-frequency trading company's first-quarter normalized adjusted earnings were $1.30 per share, topping the $1.20 a share consensus estimate, according to FactSet. The results led Jefferies to increase its estimates for 2025 and 2026 earnings to $4.10 and $4.05 per share, respectively, from $3.74 and $3.78 per share. Elevated volatility and increased retail participation have been key drivers of Virtu Financial's recent earnings strength, as well as the company's growth initiatives, Jefferies analyst Daniel Fannon said in an April note after the company's earnings report. "While the sustainability of activity is always an unknown, the diversity of asset class/product contribution to the performance is notable (this quarter, metals were highlighted for the first time in recent history)," he wrote. "The growth and investor participation within Virtu's underlying markets, such as options, ETFs, crypto, and equity ownership more broadly continue to represent longer-term tailwinds to Virtu's growth outlook." The stock pays a 2.33% dividend yield. Lastly, STAG Industrial has a 4.21% dividend yield and is up nearly 5% so far this year. The real estate investment trust, which focuses on industrial properties in the U.S., has 29% upside to Jefferies' $45 price target, as of Tuesday's close. The company's first-quarter core funds from operations came in at 61 cents per share, 1 cent above the FactSet consensus estimate. Its revenue was $205.6 million, above the $201.1 million expected by analysts. Cash-leashing spreads — which is the difference between money collected on new and renewal leases compared to expiring lease — jumped 27.3%, analyst Jonathan Petersen pointed out in an April 29 note, after the company reported earnings. "We expect leasing spreads will continue to trend positively vs coastal peers over the next few years driven by demand related to onshoring of manufacturing and supply chain reconfiguration," he wrote.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Is This the Right Time to Consider Healthcare ETFs?
Is This the Right Time to Consider Healthcare ETFs?

Yahoo

time7 minutes ago

  • Yahoo

Is This the Right Time to Consider Healthcare ETFs?

U.S. healthcare stocks are currently trading at the biggest discount relative to the broader market in 30 years, according to Barrons, presenting a solid opportunity for investors looking for stability and potential growth. The Health Care Select Sector SPDR XLV, which mirrors the sector's performance, has fallen 9.6% over the past year while the broad SPDR S&P 500 ETF Trust SPY climbed about 16%. This has pushed healthcare stocks to trade at a historic valuation discount compared to the broader market. The sector has been struggling due to concerns over political and regulatory uncertainties, including government policies targeting prescription drug prices, tariffs on pharmaceuticals, and reduced funding in health research and Medicaid. The expiry of drug patents and setbacks faced by major companies have contributed to the sector's another sign of waning investor interest, healthcare ETFs have recorded 12 straight months of net outflows through July, totaling $11.5 billion. This represents the largest outflow of any sector, according to State Street Investment Management. Is the Sector Ready for a Rebound? The healthcare sector has gathered momentum with XLV gaining 4.2% over the past week versus a decline of 0.5% for SPY. This signals potential turnaround and came on the back of attractive valuation and growing hedge fund's exposure. Attractive Valuation The sector is currently trading at a forward P/E ratio of around 16, substantially lower than the S&P 500's P/E ratio of about 22 and far below technology's P/E ratio of 30. This discount is the widest seen in three decades, making healthcare stocks some of the most undervalued in the market relative to their earnings potential. Buffett Entry Provides A Major Boost Warren Buffett's Berkshire Hathaway investment in UnitedHealth UNH lifted sentiment, bolstering confidence in managed-care names. In the latest 13F filing, Berkshire Hathaway disclosed that it bought more than 5 million shares in UNH in the second quarter, valued at approximately $1.6 billion. The stock has soared more than 10% in a week (read: Insights Into 13F Filings: ETFs to Invest in Like Billionaires). Other Hedge Funds Increase Exposure Per the latest 13F filings, most hedge funds ramped up exposure to healthcare stocks. Stanley Druckenmiller, renowned investor and head of Duquesne Family Office, has increased his exposure to healthcare stocks as part of a strategic portfolio adjustment during the second quarter. His portfolio, valued at around $3.06 billion, shows a prominent tilt toward innovative healthcare and pharmaceuticals, reflecting his confidence in the sector's growth managers also highlighted exposure to Regeneron REGN and other life sciences names via both equity and calls, showing targeted science-driven bets. Corporate Action Stocks like CVS Health CVS gained on analyst upgrades. Novo Nordisk NVO surged following the FDA approval for a new use of its weight-loss drug (read: NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain). Rotation to Defensive Sectors Amid growing skepticism over lofty tech valuations, investors are shifting toward more stable, defensive sectors. This has helped healthcare stocks attract renewed attention as a safer haven. Healthcare generally outperforms during periods of low growth and high uncertainty, as evidenced in the current macro environment. AI and Technology Integration in Healthcare The emergence of AI-driven healthcare initiatives, such as the Stargate project, promised to revolutionize cancer research and healthcare technologies. This created optimism about innovation-led growth in the sector, attracting investments focused on AI and biotech companies advancing healthcare solutions. Solid Zacks Sector Rank The potential upside to the healthcare sector is confirmed by the Zacks Sector Rank in the top 44%, with about 75% of the industries ranking in the top 41%. This suggests that the momentum built up in the healthcare space lately will likely continue in the coming weeks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Novo Nordisk A/S (NVO) : Free Stock Analysis Report CVS Health Corporation (CVS) : Free Stock Analysis Report SPDR S&P 500 ETF (SPY): ETF Research Reports Health Care Select Sector SPDR ETF (XLV): ETF Research Reports This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nvidia's Earnings Could Make Or Break Momentum ETFs
Nvidia's Earnings Could Make Or Break Momentum ETFs

Yahoo

time7 minutes ago

  • Yahoo

Nvidia's Earnings Could Make Or Break Momentum ETFs

A sudden tumble in the high-flying factor names could be paving the way for a reversal, say Goldman Sachs traders, putting the spotlight on ETFs tied to the factor ahead of NVIDIA Corp.'s (NASDAQ:NVDA) closely followed earnings next week. Nvidia's quarterly results could decide the fate of momentum stocks and the ETFs that track them, after a two-week slide put the high-flying trade under pressure. Nvidia is down more than 4% in the past week. Track its prices live, here. Goldman's High Beta Momentum basket, which bundles together the latest winners in the market and shorts losers, fell 13% from Aug 6 to Aug 19, its fourth drop of over 10% this year, as reported by Bloomberg. Historically, these sharp declines have tended to reverse rapidly from such a point. Goldman Sachs pointed out that in previous instances when the basket declined 10% or more in five days, it recovered during the next week, 80% of the time, with median returns of 4.5% during the next week and over 11% over the subsequent month. The ETF Angle Momentum-based ETFs such as the iShares MSCI USA Momentum Factor ETF (BATS:MTUM) and Invesco Dorsey Wright Momentum ETF (NASDAQ:PDP) offer investors direct exposure to the same high-octane growth stocks that dominate Goldman's basket, the likes of Nvidia, Advanced Micro Devices Inc (NASDAQ:AMD), and Palantir Technologies Inc (NASDAQ:PLTR). That makes the funds especially sensitive to whether Nvidia's earnings next week can revive enthusiasm in AI-related equities or deepen the selloff. ETFs that follow the momentum factor have also experienced uneven returns in 2025, with several abrupt swings related to the AI trade. The latest rout also questions whether these vehicles can be used as tactical trades or not long-term positions. What's Driving The Sell-off Losses in AI leaders such as Palantir, AMD, Super Micro Computer Inc (NASDAQ:SMCI), and even Nvidia, pulled the basket down. These formerly crowded trades now face profit-taking, high valuations, and nervousness about China's competitive squeeze. The Risk To Rebounds Although Goldman's traders point out that momentum has previously rebounded following steep drops, some warn that the factor has been erratic throughout the year. Bloomberg Intelligence's Christopher Cain said that high-momentum stocks have some of the most costly valuations relative to low momentum in history. The last catalyst will depend on Nvidia's earnings next week. As the heaviest weight in the S&P 500 and Nasdaq 100, the chipmaker's report could make or break whether momentum ETFs produce another record rebound — or this is merely the beginning of a more significant correction. Read Next: Photo: Chung-Hao-Lee via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? NVIDIA (NVDA): Free Stock Analysis Report This article Nvidia's Earnings Could Make Or Break Momentum ETFs originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Are Wall Street Analysts Bullish on Federal Realty Stock?
Are Wall Street Analysts Bullish on Federal Realty Stock?

Yahoo

time22 minutes ago

  • Yahoo

Are Wall Street Analysts Bullish on Federal Realty Stock?

Federal Realty Investment Trust (FRT), with a market cap of $8.3 billion, is a real estate company that owns, operates and redevelops high-quality retail-based properties located primarily in major coastal markets. The North Bethesda, Maryland-based company's retail properties are anchored by supermarkets, drugstores, or high-volume, value-oriented retailers, which provide essential 1consumer necessities. Shares of this retail REIT have underperformed the broader market over the past 52 weeks. FRT has declined 14.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.3%. Moreover, on a YTD basis, the stock is down 13.6%, compared to SPX's 9% rise. More News from Barchart As SoFi Launches International Money Transfer Services, How Should You Play SOFI Stock? This Cannabis Stock Just Transformed Into a Bitcoin Treasury Play. Should You Buy Shares Now? Profiting from Volatility: CRWV Long Straddle Trade Setup Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Narrowing the focus, FRT has also lagged behind the Real Estate Select Sector SPDR Fund's (XLRE) 1% uptick over the past 52 weeks and 2.5% return on a YTD basis. On Aug. 6, Federal Realty reported Q2 results that topped Wall Street expectations. Its funds from operations stood at $165.5 million, or $1.91 per share, beating the consensus estimate of $1.73 per share. Net income was $153.9 million, or $1.78 per share, while revenue came in at $311.5 million, slightly above forecasts of $310.7 million. The company projects full-year funds from operations in the range of $7.16 to $7.26 per share. Shares of the company declined marginally post the announcement. For the current fiscal year, ending in December, analysts expect FRT's FFO to grow 5.9% year over year to $7.17 per share. The company's FFO surprise history is mixed. It exceeded or met the consensus estimates in three of the last four quarters, while missing on another occasion. Among the 18 analysts covering the stock, the consensus rating is a 'Moderate Buy' which is based on nine 'Strong Buy,' one 'Moderate Buy,' and eight 'Hold' ratings. This configuration has been consistent for the past months. On Aug. 8, Evercore ISI analyst Steve Sakwa reaffirmed an 'Outperform' rating on Federal Realty Investment while slightly lowering the price target from $109 to $107, a 1.8% reduction. The mean price target of $107.50 represents an 11.2% premium from FRT's current price levels, while the Street-high price target of $115 suggests an upside potential of 18.9%. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store